Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-02

FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (Naari Pte Limited)

View source ↗

Summary

FDA approves a supplemental application for the generic combined oral contraceptive Norgestimate and Ethinyl Estradiol from Naari Pte Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORGESTIMATE AND ETHINYL ESTRADIOL (norgestimate and ethinyl estradiol)

Snippet

SUPPL AP for NORGESTIMATE AND ETHINYL ESTRADIOL (NORGESTIMATE AND ETHINYL ESTRADIOL)